CJC-1295 DAC vs No DAC: Which to Choose

CJC-1295 comes in two versions that share the same base peptide but behave completely differently in the body. The DAC (Drug Affinity Complex) version binds to albumin and lasts over a week. The no-DAC version (also called mod GRF 1-29 or modified GRF 1-29) is cleared in about 30 minutes. That single pharmacokinetic difference changes the dosing protocol, the GH release pattern, the stacking strategy, and potentially the results.

This comparison breaks down every meaningful difference to help you choose the right version for your goals.

Quick Comparison Table

Mechanism of Action: Same Receptor, Different Kinetics

Both versions activate the GHRH receptor (GHRHR) on pituitary somatotropes. The amino acid sequence of the active peptide is identical — both are modified GHRH (1-29) analogs with four amino acid substitutions (Ala2, Gln8, Ala15, Leu27) that improve enzymatic stability.

The difference is what happens after injection:

CJC-1295 DAC: A reactive chemical group (the DAC moiety) covalently bonds to serum albumin within minutes of injection. Since albumin has a half-life of ~20 days, this essentially turns the peptide into a slow-release depot. The result: continuous GHRH receptor stimulation for 6-14 days (Teichman et al., 2006).

CJC-1295 No DAC: Without the albumin-binding modification, the peptide circulates freely and is degraded by peptidases within ~30 minutes. Each injection produces a brief but potent GHRH pulse, stimulating a discrete GH spike that resolves within 2-3 hours.

GH Release Pattern: Pulses vs Bleed

This is the most important functional difference and the core of the DAC/no-DAC debate.

No DAC: Pulsatile GH (More Physiological)

The body naturally secretes GH in pulses — sharp spikes followed by return to baseline. The largest pulse occurs during the first phase of slow-wave sleep. CJC-1295 no DAC mimics this pattern: each injection triggers a discrete GH pulse, and between injections, GH returns to baseline.

When paired with a GHRP (ipamorelin, GHRP-2), the combined GHRH + GHRP receptor activation produces a synergistic GH pulse 5-10x greater than either alone. This is why the no-DAC + ipamorelin stack is considered the gold standard for GH secretagogue use.

DAC: Sustained GH Elevation (GH Bleed)

CJC-1295 DAC raises baseline GH levels continuously. Ionescu & Frohman (2006) showed that basal (trough) GH levels increased 7.5-fold while pulse frequency and magnitude were preserved (PMID: 17018654). So you still get GH pulses — they just ride on top of a much higher baseline.

This "GH bleed" means 24/7 GH stimulation. It is more convenient but less physiological. The elevated baseline may increase risk of insulin resistance compared to pulsatile release, though this has not been directly compared in clinical trials.

Efficacy Comparison

IGF-1 Elevation

Both versions effectively raise IGF-1, the downstream mediator of most GH benefits:

• DAC: 1.5-3 fold increase sustained for 9-11 days after a single injection (PMID: 16352683)
• No DAC: IGF-1 elevation depends on cumulative daily pulse effect. With 2-3 daily injections + GHRP, comparable IGF-1 increases are achieved

No head-to-head trial has compared steady-state IGF-1 levels between the two versions at equivalent community doses.

Body Composition

Community reports suggest similar body composition outcomes from both versions over 8-12 week cycles. The theoretical advantage of pulsatile GH (no-DAC) for fat loss is based on the observation that GH's lipolytic effect may be more potent in a pulsatile pattern. However, the sustained IGF-1 from DAC also promotes fat oxidation and lean mass preservation.

Bottom line: Both work. The difference in body composition outcomes is likely small compared to the impact of training, nutrition, and total IGF-1 exposure.

Sleep Quality

Both versions improve sleep quality, but through slightly different mechanisms:

• DAC: Continuous GHRH stimulation enhances the nocturnal GH surge from an elevated baseline
• No DAC: Pre-bed injection directly amplifies the natural sleep-onset GH pulse

Community reports of sleep improvement are consistent for both versions.

Side Effects Comparison

Cost Comparison

The cost calculation is not as straightforward as comparing vial prices:

DAC is slightly cheaper when you factor in that no-DAC practically requires a GHRP pairing to be effective, which adds to the cost. However, prices vary significantly between vendors. Check current pricing on the CJC-1295 DAC and CJC-1295 vendor pages.

Stacking Considerations

CJC-1295 No DAC Stacking (Standard Approach)

The no-DAC version is designed to be stacked. GHRH + GHRP co-injection is the standard protocol:

• CJC-1295 no DAC + Ipamorelin — Gold standard. Clean GH pulse, minimal side effects
• CJC-1295 no DAC + GHRP-2 — Stronger GH output, more hunger, slight cortisol elevation
• CJC-1295 no DAC + Hexarelin — Maximum GH pulse, but desensitization risk with prolonged use

Inject both peptides simultaneously, in the same syringe if desired. The synergistic effect only works with timed co-injection.

CJC-1295 DAC Stacking (Less Clear-Cut)

Because the GHRH receptor is already continuously occupied, adding timed GHRPs does not produce the same synergistic pulse amplification. Options:

• DAC + bedtime ipamorelin — Hybrid approach: DAC for baseline elevation, ipamorelin for sleep pulse enhancement
• DAC alone — Many users run DAC standalone successfully

Do NOT Stack DAC + No-DAC

Running both versions simultaneously is redundant. The DAC version already provides continuous GHRH receptor stimulation. Adding no-DAC on top provides no additional benefit and may increase side effects.

The Verdict: Which Version to Choose

Choose CJC-1295 DAC if:

• You want minimal injection frequency (1-2x/week)
• You travel frequently or have an unpredictable schedule
• You find daily fasted injections unsustainable
• You prefer a simpler protocol without GHRP pairing
• You want the version with published human clinical data

Choose CJC-1295 No DAC if:

• You want the most physiological GH release pattern
• You are comfortable with 2-3 daily injections on an empty stomach
• You plan to stack with ipamorelin or another GHRP for maximum effect
• You are concerned about insulin resistance from sustained GH elevation
• You want more control over injection timing (targeting sleep and post-workout windows)

The community consensus: No-DAC + ipamorelin is the more popular combination for performance-focused users willing to commit to the daily protocol. DAC is chosen by users who prioritize convenience and compliance. Results over a full cycle are comparable when both are used correctly.

Frequently Asked Questions

What is the main difference between CJC-1295 DAC and no DAC?

Half-life. DAC lasts 5.8-8.1 days due to albumin binding. No DAC lasts ~30 minutes. This drives every other difference: injection frequency, GH release pattern, GHRP stacking strategy, and side effect profile.

Which version produces larger GH pulses?

No DAC, when paired with a GHRP. The timed co-injection produces GH spikes 5-10x greater than either peptide alone. DAC raises baseline GH but does not produce the same acute pulse amplification.

Is CJC-1295 DAC safer than no DAC?

DAC has more published human safety data. However, the sustained GH elevation may carry greater metabolic risk (insulin resistance) compared to pulsatile release. Neither version has long-term safety data in the community dosing context.

Can you switch between versions?

Yes. Allow 2 weeks after stopping DAC before starting no-DAC to ensure clearance. No washout is needed when switching from no-DAC to DAC.

Which is cheaper per month?

Similar overall cost. DAC vials cost more but you use fewer. No-DAC is cheaper per vial but requires more vials plus GHRP pairing. Total monthly cost is roughly $50-240 for either approach depending on vendor and protocol.

Related Reading

• CJC-1295 DAC Dosing Guide — complete weekly protocol for the long-acting version
• CJC-1295 DAC Benefits — 5 effects of sustained GH elevation ranked by evidence
• CJC-1295 No DAC Dosing Guide — daily protocol with GHRP stacking
• CJC-1295 + Ipamorelin Guide — the gold standard GH stack
• CJC-1295 vs Sermorelin — comparing different GHRH analogs

References

This is not medical advice. Both CJC-1295 versions are research peptides. The no-DAC form has no direct human clinical trials. Community protocols are based on published clinical data from the DAC version and GHRH/GHRP pharmacology. Consult a qualified healthcare provider before use.